Frank Kanniess
- Beclometasone/formoterol administered via extrafine dry powder inhaler in controlled asthmatic patients: Comparison with pMDI and beclometasone monotherapyBy Francesco Sergio, Catherine Francisco, Annamaria Muraro and Frank KanniessFrancesco Sergio1Corporate Clinical Development, Chiesi Farmaceutici S.p.A., Parma, ItalyCatherine Francisco1Corporate Clinical Development, Chiesi Farmaceutici S.p.A., Parma, ItalyAnnamaria Muraro1Corporate Clinical Development, Chiesi Farmaceutici S.p.A., Parma, ItalyFrank Kanniess1Corporate Clinical Development, Chiesi Farmaceutici S.p.A., Parma, Italy
- Effects of low- vs high-dose fluticasone/formoterol combination therapy on AMP challenge in asthmatic patientsBy Frank Kanniess, Zuzana Diamant, Mark Lomax and Meena JainFrank Kanniess1Practice for Allergy and Family Medicine, Practice for Allergy and Family Medicine, Reinfeld, GermanyZuzana Diamant2Department of Respiratory Medicine and Allergology, Institute for Clinical Science, Skane University Hospital, Lund, SwedenMark Lomax3Clinical Data Management and Statistics, Mundipharma Research Limited, Cambridge, United KingdomMeena Jain4Medical Science - Respiratory, Mundipharma Research Limited, Cambridge, United Kingdom
- Mometasone furoate delivered via the Breezhaler® and Twisthaler® devices in asthmaBy Frank Kanniess, Gerald Hanf, Motoi Hosoe, Ana-Marie Tanase, Soniya Vaidya, Rudrani Banerjee and Bettina HedererFrank Kanniess1Allergology, Gemeinschaftspraxis Reinfeld, Reinfeld, GermanyGerald Hanf2Department of Internal Medicine, Respiratory and Infectious Diseases, Das UntersuchungsZentrum für Dermatologie, Allergologie und Asthma (UZDAA), Berlin, GermanyMotoi Hosoe3Primary Care, Novartis Pharma AG, Basel, SwitzerlandAna-Marie Tanase3Primary Care, Novartis Pharma AG, Basel, SwitzerlandSoniya Vaidya4Primary Care, Novartis Institutes for BioMedical Research, Cambridge,Rudrani Banerjee5Primary Care, Novartis Healthcare Pvt. Ltd., Hyderabad, IndiaBettina Hederer3Primary Care, Novartis Pharma AG, Basel, Switzerland
- Clinical asthma phenotypes in the real world: opportunities and challengesBy Clementine Bostantzoglou, Vicky Delimpoura, Konstantinos Samitas, Eleftherios Zervas, Frank Kanniess and Mina GagaClementine Bostantzoglou17th Respiratory Medicine Dept. and Asthma Center, Athens Chest Hospital “Sotiria”, Athens, GreeceVicky Delimpoura17th Respiratory Medicine Dept. and Asthma Center, Athens Chest Hospital “Sotiria”, Athens, GreeceKonstantinos Samitas17th Respiratory Medicine Dept. and Asthma Center, Athens Chest Hospital “Sotiria”, Athens, GreeceEleftherios Zervas17th Respiratory Medicine Dept. and Asthma Center, Athens Chest Hospital “Sotiria”, Athens, GreeceFrank Kanniess2FA Allgemeinmedizin, Allergologie, Bahnhofstrasse 5a, D–23858, ReinfeldMina Gaga17th Respiratory Medicine Dept. and Asthma Center, Athens Chest Hospital “Sotiria”, Athens, Greece
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.